Practical application of nitric oxide technology to the treatment of vascular diseases

Lumen Therapeutics is a privately held, development stage biopharmaceutical company focused on proprietary drugs based on oligo-L-arginine.

The company's lead product has completed a Phase I/IIa clinical trial for the prevention of vein graft failure after bypass graft surgery. Several additional molecules are in preclinical development. read more...